NeumannFJSousa-UvaMAhlssonA, et al.2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J2019; 40: 87–165.
2.
AboyansVRiccoJBBartelinkML, et al.ESC Scientific Document Group, 2017 ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Eur Heart J2018; 39: 763–816.
3.
Gerhard-HermanMDGornikHLBarrettC, et al.AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol2017; 69: 1465–1465.
4.
Venermo M, Sprynger M, Desormais I, et al. Follow-up of patients after revascularization for peripheral arterial diseases. A consensus document from the European Society of Cardiology (ESC) Working Group on Aorta & Peripheral Vascular Diseases and the European Society of Vascular Surgery (ESVS). Eur J Prev Cardiol. 2019; 26: 1971–1984.
5.
StegPGBhattDLWilsonPW, et al.One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA2007; 297: 1197–1206.
6.
ShalaevaESanerHJanabaevB, et al.Tenfold risk increase of major cardiovascular events after high limb amputation with non-compliance for secondary prevention measures. Eur J Prev Cardiol2017; 24(7): 708–716.
7.
JernbergTHasvoldPHenrikssonM, et al.Cardiovascular risk in post-myocardial infarction patients: Nationwide realworld data demonstrate the importance of a long-term perspective. Eur Heart J2015; 36: 1163–1170.
8.
GrobbeeDEPelliciaA. Secondary prevention of cardiovascular disease: Unmet medical need, implementation and innovation. Eur J Prev Cardiol2017; 24: 5–7.
9.
HamburgNMBaladyGJ. Exercise rehabilitation in peripheral artery disease: Functional impact and mechanisms of benefits. Circulation2011; 123: 87–97.
10.
KotsevaKDe BackerGDe BacquerD, et al.Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V Registry. Eur J Prev Cardiol2019; 26: 824–835.
11.
BodenWEO’RourkeRATeoKK, et al.Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med2007; 356: 1503–1516.
12.
Al-LameeRThompsonDDehbiHM, et al.Percutaneous coronary intervention in stable angina (ORBITA): A double-blind, randomised controlled trial. Lancet2018; 391: 31–40.
13.
WheatleyKIvesNGrayR, et al.Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med2009; 361: 1953–1962.
14.
MurphyTPCutlipDERegensteinerJG, et al.Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: Six-month outcomes from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) study. Circulation2012; 125: 130–139.
15.
PiepoliMFCorràUDendaleP, et al.Challenges in secondary prevention after acute myocardial infarction: A call for action. Eur J Prev Cardiol2016; 23: 1994–2006.
16.
FaridiKFPetersonEDMcCoyLA, et al.Timing of First postdischarge follow-up and medication adherence after acute myocardial infarction. JAMA Cardiol2016; 1: 147–155.
17.
HoPMLutherSAMasoudiFA, et al.Inpatient and follow-up cardiology care and mortality for acute coronary syndrome patients in the Veterans Health Administration. Am Heart J2007; 154: 489–494.
18.
GiannuzziPTemporelliPLMarchioliR, et al.Global secondary prevention strategies to limit event recurrence after myocardial infarction: Results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network. Arch Intern Med2008; 168: 2194–2204.
19.
HuberDHenrikssonRJakobssonS, et al.Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial. PLoS One2017; 12: e0183963–e0183963.
20.
Marcos-ForniolEMecoJFCorbellaE, et al.Secondary prevention programme of ischaemic heart disease in the elderly: A randomised clinical trial. Eur J Prev Cardiol2018; 25: 278–286.
